首页> 外文期刊>The journal of sexual medicine >Measuring women's satisfaction with treatment for sexual dysfunction: development and initial validation of the Women's Inventory of Treatment Satisfaction (WITS-9).
【24h】

Measuring women's satisfaction with treatment for sexual dysfunction: development and initial validation of the Women's Inventory of Treatment Satisfaction (WITS-9).

机译:衡量妇女对性功能障碍治疗的满意度:妇女治疗满意度调查表(WITS-9)的开发和初步验证。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To develop a brief, psychometrically sound, measure of satisfaction with treatment for female sexual arousal disorder. METHOD: In Phase 1, women in focus groups generated items measuring satisfaction with treatment for arousal disorder. In Phase 2, expert clinicians/researchers and women with self-reported female sexual arousal disorder (FSAD) assessed the content validity of the items. In Phase 3, women enrolled in a double-blind treatment trial for female sexual dysfunction completed the Women's Inventory of Treatment Satisfaction (WITS) and the Female Sexual Function Inventory (FSFI) to provide reliability and validity information. MAIN OUTCOME MEASURES: WITS and FSFI. RESULTS: In Phase 2, 36 items demonstrated adequate content validity. In Phase 3, 20 items correlated with symptom improvement on the FSFI arousal subscale. Factor analysis sorted these items into three dimensions: initiation/receptivity satisfaction, treatment satisfaction, and perceived partner satisfaction. The three items with the highest loadings on each factor formed the WITS-9. Internal consistency (alpha) reliability coefficients for the total WITS-9 score and the three subscale scores were 0.92, 0.93, 0.92, and 0.79, respectively. Correlations of WITS-9 scores with the FSFI change scores for subgroups with different sexual dysfunctions offer construct validity support that the WITS-9 measures treatment satisfaction for women with a variety of sexual dysfunctions. CONCLUSION: The WITS-9 is a brief, psychometrically sound scale that is useful for assessing treatment satisfaction in women with sexual dysfunctions. While the WITS-9 is promising, further work needs to be done to obtain reliability and validity information in additional samples.
机译:目的:建立一种简短的,心理上合理的,对女性性唤起障碍治疗满意度的方法。方法:在第1阶段,焦点小组中的妇女生成了衡量唤醒性疾病治疗满意度的项目。在第2阶段中,专业的临床医生/研究人员以及患有自我报告的女性性唤起障碍(FSAD)的妇女评估了这些内容的有效性。在第3阶段中,参加了针对女性性功能障碍的双盲治疗试验的女性填写了《女性治疗满意度表》(WITS)和《女性性功能表》(FSFI),以提供信度和效度信息。主要观察指标:机智和FSFI。结果:在第2阶段中,有36个项目显示了足够的内容有效性。在第3阶段中,有20项与FSFI唤醒子量表的症状改善相关。因子分析将这些项目分为三个维度:初始/接受性满意度,治疗满意度和感知伴侣满意度。 WITS-9由每个因子上最高负载的三个项目组成。 WITS-9总得分和三个分量表得分的内部一致性(α)可靠性系数分别为0.92、0.93、0.92和0.79。对于具有不同性功能障碍的亚组,WITS-9评分与FSFI变化评分之间的相关性提供了结构效度支持,WITS-9可以衡量各种性功能障碍女性的治疗满意度。结论:WITS-9是一种简短的,从心理角度上合理的量表,可用于评估性功能障碍妇女的治疗满意度。尽管WITS-9前景广阔,但需要做更多的工作才能获得更多样本中的可靠性和有效性信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号